Complex between human insulin and an amphiphilic polymer and use of this complex in the preparation of a fast-acting human insulin formulation
AssigneeAdocia
InventorsOlivier Soula, Remi Soula, Gerard Soula
Life of this patent
Estimating the term…
Loading patent…
AssigneeAdocia
InventorsOlivier Soula, Remi Soula, Gerard Soula
Estimating the term…
The invention relates to a complex between human insulin and an amphiphilic polymer comprising carboxyl functional groups, said amphiphilic polymer being chosen from functionalized polysaccharides predominantly composed of glycoside monomers bonded via glycoside bonds of (1,6) type which are functionalized by at least one tryptophan derivative. It also relates to a pharmaceutical composition comprising at least one complex according to the invention, it being possible for said formulation to be in the form of an injectable solution. It more particularly relates to the use of a complex according to the invention in the preparation of a human insulin formulation at a concentration of approximately 600 μM (100 IU/ml), the onset of action of which is less than 30 minutes, preferably less than 20 minutes and more preferably less than 15 minutes and/or the glycemic nadir of which is at less than 120 minutes, preferably less than 105 minutes and more preferably less than 90 minutes.
A complex between human insulin and an amphiphilic polymer comprising carboxyl functional groups, said amphiphilic polymer being chosen from functionalized polysaccharides predominantly composed of glycoside monomers bonded via glycoside bonds of (1,6) type which are functionalized by at least one tryptophan derivative, which polysaccharides are chosen from the polysaccharides of formula I:
Dependencies are inferred from the claim text.